Порядковый номер ссылки	Авторы, название публикации и источника, где она опубликована, выходные данные	ФИО, название публикации и источника на английском	Полный интернет-адрес (URL) цитируемой статьи или ее doi.	
1	Аверина О.В., Ермоленко Е. И., Ратушный А.Ю., Тарасова Е.А., Борщев Ю.Ю., Леонтьева Г.Ф., Крамская Т.А., Котылева М.П., Даниленко В.Н., Суворов А.Н. Влияние пробиотиков на продукцию цитокинов в системах in vitro и in vivo // Медицинская иммунология. – 2015. – Т. 17, №5. – С. 443-454.	Averina O.V., Ermolenko E.I., Ratushniy A.Yu., Tarasova E.A., Borschev Yu.Yu., Leontieva G.F., Kramskaya T.A., Kotyleva M.P., Danilenko V.N., Suvorov A.N. Influence of probiotics on cytokine production in the in vitro and in vivo systems. Medical Immunology (Russia)/Meditsinskaya Immunologiya, 2015, Vol. 17, no.5, pp. 443-454. 	https://www.mimmun.ru/mimmun/article/view/932/821 [doi: 10.15789/1563-0625-2015-5-443-454]	
2	Бельмер, С.В. Иммунологические аспекты синдрома раздраженного кишечника // Лечащий врач. – 2016. –  №8. – С. 14-18.	Belmer S.V. Immunologic aspects of irritable bowel syndrome. Lechaschij vrach, 2016, no. 8, pp. 14-18.	https://www.lvrach.ru/2016/08/15436526/	
3	Головкин А.С., Асадуллина И.А., Кудрявцев И.В. Пуринергическая регуляция основных физиологических и патологических процессов // Медицинская иммунология. – 2018. – Т. 20, №4б. – С. 463-476. 	Golovkin A.S., Asadullina I.A., Kudryavtsev I.V. Purinergic regulation of basic physiological and pathological processes. Medical Immunology (Russia), 2018, Vol. 20, no.4, pp. 463-476. 	https://www.mimmun.ru/mimmun/article/view/1556/1043 [doi: 10.15789/1563-0625-2018-4-463-476]	
4	Ивашкин В.Т., Маев И.В., Шептулин А.А., Трухманов А.С., Алексеева О.П., Баранская Е.К., Ивашкин К.В., Калинин А.В., Корочанская Н.В., Кучерявый Ю.А., Лапина Т.Л., Плотникова Е.Ю., Полуэктова Е.А., Симаненков В.И., Сторонова, А.В. Ткачев О.А., Шифрин О.С., Тарасова Л.В., Хлынов И.Б. Резолюция экспертного совета «Как улучшить результаты лечения больных с функциональной диспепсией и синдромом раздраженного кишечника» // РЖГГК. – 2016.– №2.– С. 101–104.	V.T. Ivashkin, I.V. Mayev, A.A. Sheptulin, A.S. Trukhmanov, O.P. Alekseyeva, Ye.K. Baranskaya, K.V. Ivashkin, A.V. Kalinin, N.V. Korochanskaya, Yu.A. Kucheryavy, T.L. Lapina, Ye.Yu. Plotnikova, Ye.A. Poluektova, V.I. Simanenkov, O.A. Storonova, A.V. Tkachyov, О.S. Shifrin, L.V. Tarasova, I.B. Khlynov. The resolution of Advisory council «How to improve treatment results functional dyspepsia and irritable bowel syndrome»? Russian journal of gastroenterology, hepatology, coloproctology, 2016, no.2, pp. 101–104.	https://www.gastro-j.ru/jour/article/view/40/28	
5	Кудрявцев И.В., Ермоленко Е.И., Соловьева О.И., Серебрякова М.К., Шумихина И.А., Суворов А.Н.  Субпопуляционный состав т- лимфоцитов при синдроме раздраженного кишечника // Экспериментальная и клиническая гастроэнтерология. – 2019. – №5. – С.  22-28. 	Kudryavtsev I.V., Ermolenko E.I., Solovieva O.V., Serebriakova M. K., Shumikhina I.A., Suvorov A.N. Subpopulation composition of T-lymphocytes in patients with irritatable intestinal syndrome. Experimental and clinical gastroenterology, 2019, no.5, pp. 22-28.	https://elibrary.ru/item.asp?id=41304697

[doi: 10.31146/1682-8658-ecg-165-5-22-28]
	
6	Ситкин, С. И., Ткаченко, Е. И., Вахитов, Т. Я. Метаболический дисбиоз кишечника и его биомаркеры // Экспериментальная и клиническая гастроэнтерология. – 2015. –  №12. – C. 6-29.	Sitkin S.I., Tkachenko E.I., Vakhitov T.Y. Metabolic dysbiosis of the gut microbiota and its biomarkers. Experimental and clinical gastroenterology, 2015, no.12, pp. 6-29.	https://elibrary.ru/item.asp?id=26512178	
7	Соловьева О.И., Симаненков В.И., Суворов А.Н., Ермоленко Е.И., Шумихина Д.А., Свиридо Д.А. Использование пробиотиков и аутопробиотиков в лечении синдрома раздраженного кишечника // Экспериментальная и клиническая гастроэнтерология. – 2017. – №7. – С.115-120.	Solov’eva O.I., Simanenkov V. I., Suvorov A. N., Ermolenko E. I., Shumihina I. A., Svirido D. A. The use of probiotics and autoprobiotics in the treatment of irritable bowel syndrome. Experimental and clinical gastroenterology / Eksperimental’naya i Klinicheskaya Gastroenterologiya, 2017, no.7, pp. 115–120.	http://nogr.org/images/Article/2017/G_07_2017_In-12_115-120.pdf	
8	Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян Арег А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (Проект) // Медицинская иммунология. – 2012. – Т. 14, №3. – С.255-268.	Khaydukov S.V., Baydun L.A., Zurochka A.V., Totolian Areg A. Standardized technology «Research of lymphocytes subpopulation composition in peripheral blood using flow cytometry analyzers» (Draft). Medical Immunology, 2012, Vol. 14, no.3, pp. 255-268.  	https://www.mimmun.ru/mimmun/article/view/368/371 [doi:  10.15789/1563-0625-2012-3-255-268]	
9	Akehurst R.L., Brazier J.E., Mathers N., O'Keefe C., Kaltenthaler E., Morgan A., Platts M., Walters S.J. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics, 2002, Vol. 20, no. 7, pp. 455–462.	-	https://link.springer.com/article/10.2165%2F00019053-200220070-00003
[doi:  10.2165/00019053-200220070-00003]	
10	Chong P.P., Chin V.K., Looi C.Y., Wong W.F., Madhavan P., Yong V.C. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Front. Microbiol., 2019, 10:1136.	-	https://www.frontiersin.org/articles/10.3389/fmicb.2019.01136/full
[doi: 10.3389/fmicb.2019.01136]	
11	Drossman D.A., Hasler W.L. Rome IV - Functional GI disorders: disorders of gut-brain interaction.  Gastroenterology, 2016, Vol. 150, no.6, pp. 1257-1261.	-	https://www.gastrojournal.org/article/S0016-5085(16)30048-8/fulltext
[doi: 10.1053/j.gastro.2016.03.035]	
12	Forshammar J., Isaksson S., Strid H., Stotzer P.O., Sjövall H., Simrén M., Ohman L. A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol., 2008, Vol. 43, no.12, pp. 1461-1466.	- 	https://www.tandfonline.com/doi/abs/10.1080/00365520802272126?journalCode=igas20
[doi: 10.1080/00365520802272126]	
13	Gonsalkorale W.M., Perrey C., Pravica V., Whorwell P.J., Hutchinson I.V. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut, 2003, Vol. 52, no.1, pp. 91-93.	-	https://gut.bmj.com/content/52/1/91
[doi: 10.1136/gut.52.1.91]	
14	Grant C.R., Liberal R., Mieli-Vergani G., Vergani D., Longhi M.S. Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. Autoimmun. Rev., 2015, Vol. 14, pp. 105-116.	-	https://www.sciencedirect.com/science/article/pii/S1568997214002249?via%3Dihub
[doi: 10.1016/j.autrev.2014.10.012]	
15	Hod K., Ringel-Kulka T., Martin C.F., Maharshak N., Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol., 2016, Vol. 50, no.3, pp. 227-232.	-	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950940/  [doi: 10.1097/MCG.0000000000000327]	
16	Holmén N., Isaksson S., Simrén M., Sjövall H., Ohman L. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients. Neurogastroenterol Motil., 2007, Vol.19, no.2, pp.119-125.	-	https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2982.2006.00878.x [doi: 10.1111/j.1365-2982.2006.00878.x]	
17	Kassinen A., Krogius-Kurikka L., Mäkivuokko H., Rinttilä T., Paulin L., Corander J., Malinen E., Apajalahti J., Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology, 2007, Vol. 133, no.1, pp. 24-33.	-	https://www.sciencedirect.com/science/article/abs/pii/S0016508507007342?via%3Dihub [doi:10.1053/j.gastro.2007.04.005]	
18	Kim H.Y., Kim T.S., Kim B.H.Degradation of organic sulfur compounds and the reduction of dibenzothiophene to biphenyl and hydrogen sulfide by Desulfovibrio desulfuricans M6. Biotechnology Letters, 1990, Vol.12, no.10, pp. 761-764.	-	https://www.cabdirect.org/cabdirect/abstract/19911366186 [doi: 10.1007/BF01024736]	
19	Kindt S., Van Oudenhove L., Broekaert D., Kasran A., Ceuppens J.L., Bossuyt X., Fischler B., Tack J. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil., 2009, Vol. 21, no. 4, pp. 389-398.	-	https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2982.2008.01220.x [doi: 10.1111/j.1365-2982.2008.01220.x.]	
20	Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol., 2012, Vol.10, no.7, pp. 712–721. 	-	https://www.sciencedirect.com/science/article/abs/pii/S1542356512003084?via%3Dihub
[doi: 10.1016/j.cgh.2012.02.029]	
21	Lucas K. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol., 2013, Vol. 48, pp. 190–204.	-	https://link.springer.com/article/10.1007%2Fs12035-013-8425-7  [doi: 10.1007/s12035-013-8425-7]	
22	Mazmanian S.K. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 2008, Vol. 453, pp. 620-625.	-	https://www.nature.com/articles/nature07008
[doi: 10.1038/nature07008]	
23	Miquel S., Martín R., Rossi O., Bermúdez-Humarán L., Chatel J., Sokol H., Thomas M., Wells J., Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol., 2013, Vol. 16, no.3, pp. 255-261. 	-	https://www.sciencedirect.com/science/article/pii/S1369527413000775?via%3Dihub [DOI: 10.1016/j.mib.2013.06.003]	
24	Eeckhaut V., Machiels K., Perrier C., Romero C., Maes S., Flahou B., Steppe M., Haesebrouck F., Sas B., Ducatelle R., Vermeire S., Van Immerseel F. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut., 2013, Vol. 62, no.12, pp.1745-1752.	-	https://gut.bmj.com/content/62/12/1745.long [doi: 10.1136/gutjnl-2012-303611]	
25	Nasser Y., Petes C., Simmers C., Basso L., Altier C., Gee K., Vanner S.J.. Activation of Peripheral Blood CD4+ T-Cells in IBS is not Associated with Gastrointestinal or Psychological Symptoms. Sci Rep., 2019, Vol. 9, 3710.	-	https://www.nature.com/articles/s41598-019-40124-5#citeas
[doi:10.1038/s41598-019-40124-5]	
26	Nurkhametova D., Kudryavtsev I., Khayrutdinova O., Serebryakova M., Altunbaev R., Malm T., Giniatullin R. Purinergic Profiling of Regulatory T-cells in Patients With Episodic Migraine. Front Cell Neurosci., 2018, 12:326. 	-	https://www.frontiersin.org/articles/10.3389/fncel.2018.00326/full [doi: 10.3389/fncel.2018.00326]	
27	Pozuelo M., Panda S., Santiago A., Mendez S., Accarino A., Santos J., Guarner F, Azpiroz F, Manichanh C. Reduction of butyrate-and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Scientific reports, 2015, Vol.5, 12693. 	-	https://www.nature.com/articles/srep12693 [doi: 10.1038/srep12693]	
28	Rajilić-Stojanović M., Biagi E., Heilig H.G., Kajander K., Kekkonen R.A., Tims S., de Vos W.M. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 2011, Vol. 141, no.5, pp.1792-1801.	-	https://www.sciencedirect.com/science/article/abs/pii/S0016508511010766?via%3Dihub 
[doi: 10.1053/j.gastro.2011.07.043]	
29	Rigsbee L., Agans R., Shankar V., Kenche H., Khamis H. J., Michail S., Paliy O. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. The American journal of gastroenterology, 2012, Vol. 107, no.11, pp. 1740-1751. 	-	https://insights.ovid.com/pubmed?pmid=22986438 [DOI: 10.1038/ajg.2012.287]	
30	Rissiek A., Baumann I., Cuapio A., Mautner A., Kolster M., Arck P.C., Dodge-Khatami A., Mittrucker H.W., Koch-Nolte F., Haag F., Tolosa E. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J. Autoimmun., 2015, Vol. 58, pp. 12-20. 	-	https://www.sciencedirect.com/science/article/pii/S0896841114001863?via%3Dihub [doi: 10.1016/j.jaut.2014.12.007]	
31	Rodes L., Khan A., Paul A., Coussa-Charley M., Marinescu D., Tomaro-Duchesneau C., Shao W., Kahouli I., Prakash S. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J. Microbiol. Biotechnol., 2013,  Vol. 23.,  pp. 518–526.	-	http://www.jmb.or.kr/journal/viewJournal.html?doi=JMB023-04-11 [DOI:10.4014/jmb.1205.05018] 	
32	Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol., 2010, Vol. 10., pp. 490-500.	-	https://www.nature.com/articles/nri2785 
[doi: 10.1038/nri2785]	
33	Schirmer M., Smeekens S.P., Vlamakis H., Jaeger M., Oosting M., Franzosa E.A., Ter Horst R., Jansen T., Jacobs L., Bonder M.J., Kurilshikov A., Fu J., Joosten L.A.B., Zhernakova A., Huttenhower C., Wijmenga C., Netea M.G., Xavier R.J. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell, 2016, Vol.167, no.4, pp. 1125-1136.	-	https://www.sciencedirect.com/science/article/pii/S0092867416314039?via%3Dihub 
[doi: 10.1016/j.cell.2016.10.020]	
34	Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 2013, Vol. 341, pp. 569–573.	-	https://science.sciencemag.org/content/341/6145/569.long
[DOI: 10.1126/science.1241165]	
35	Suzuki D., Ueki A., Amaishi A., Ueki K. Desulfovibrio portus sp. nov., a novel sulfate-reducing bacterium in the class Deltaproteobacteria isolated from an estuarine sediment. The Journal of general and applied microbiology, 2009, Vol. 55, no.2, pp. 125-133.	-	https://www.jstage.jst.go.jp/article/jgam/55/2/55_2_125/_article [DOI:10.2323/jgam.55.125]	
36	Tana C., Umesaki Y., Imaoka A., Handa T., Kanazawa M., Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil., 2010, Vol. 22, no.5, pp. 512-519.	-	https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2982.2009.01427.x [DOI: 10.1111/j.1365-2982.2009.01427.x]	
37	Tap J., Derrien M., Törnblom H., Brazeilles R., Cools-Portier S., Doré J., Störsrud S., Le Nevé B., Öhman L., Simrén M. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology, 2017, Vol. 152, pp. 111–123. 	-	https://www.sciencedirect.com/science/article/pii/S0016508516351745?via%3Dihub
[doi: 10. 1053/j.gastro.2016.09.049]	
38	Taras D., Simmering R., Collins M. D., Lawson P. A.,  Blaut M. Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. International journal of systematic and evolutionary microbiology, 2002, Vol. 52, no. 2, pp. 423-428.	-	https://www.microbiologyresearch.org/content/journal/ijsem/10.1099/00207713-52-2-423#tab2 [DOI: 10.1099/00207713-52-2-423]